BRIEF-Spimaco Signs Term Sheet With Jiangsu Recbio Technology On HPV Vaccines

Reuters01-23

Jan 23 (Reuters) - SAUDI PHARMACEUTICAL INDUSTRIES AND MEDICAL APPLIANCES CORPORATION :

* ANNOUNCES SIGNING OF A TERM SHEET (NON-BINDING) WITH JIANGSU RECBIO TECHNOLOGY CO. ON HPV VACCINES

* SPIMACO WILL RECEIVE AN EXCLUSIVE LICENSE TO IMPORT HPV IN FINISHED PRODUCT FORM,

* SPIMACO WILL RECEIVE AN EXCLUSIVE LICENSE TO COMMERCIALIZE AND DISTRIBUTE RECBIO’S HPV VACCINE IN THE KINGDOM AND THE WIDER MENA REGION

* SPIMACO WILL RECEIVE AN EXCLUSIVE LICENSE TO LOCALIZE PRODUCTION OF HPV IN BULK FORMAT FOLLOWING CONCLUSION OF TECHNOLOGY TRANSFER

* MEMORANDUM DURATION 1 YEAR FROM DATE OF SIGNING

Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2405193039?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-01-23 13:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2405193039","market":"sh","top_or_hot":-1,"title":"BRIEF-Spimaco Signs Term Sheet With Jiangsu Recbio Technology On HPV Vaccines","media":"Reuters","content":"<html><body><p>Jan 23 (Reuters) - SAUDI PHARMACEUTICAL INDUSTRIES AND MEDICAL APPLIANCES CORPORATION   :</p><p>   * ANNOUNCES SIGNING OF A TERM SHEET (NON-BINDING) WITH JIANGSU RECBIO TECHNOLOGY CO. ON HPV VACCINES</p><p>   * SPIMACO WILL RECEIVE AN EXCLUSIVE LICENSE TO IMPORT HPV IN FINISHED PRODUCT FORM,</p><p>   * SPIMACO WILL RECEIVE AN EXCLUSIVE LICENSE TO  COMMERCIALIZE AND DISTRIBUTE RECBIO’S HPV VACCINE IN THE KINGDOM AND THE WIDER MENA REGION</p><p>   * SPIMACO WILL RECEIVE AN EXCLUSIVE LICENSE TO LOCALIZE PRODUCTION OF HPV IN BULK FORMAT FOLLOWING CONCLUSION OF TECHNOLOGY TRANSFER</p><p>   * MEMORANDUM DURATION 1 YEAR FROM DATE OF SIGNING</p><p>Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Spimaco Signs Term Sheet With Jiangsu Recbio Technology On HPV Vaccines</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Spimaco Signs Term Sheet With Jiangsu Recbio Technology On HPV Vaccines\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-01-23 13:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Jan 23 (Reuters) - SAUDI PHARMACEUTICAL INDUSTRIES AND MEDICAL APPLIANCES CORPORATION   :   * ANNOUNCES SIGNING OF A TERM SHEET (NON-BINDING) WITH JIANGSU RECBIO TECHNOLOGY CO. ON HPV VACCINES   * ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02179","symbol_name":"瑞科生物-B","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2405193039","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2405193039","pubTimestamp":1705987414,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Jan 23  - SAUDI PHARMACEUTICAL INDUSTRIES AND MEDICAL APPLIANCES CORPORATION   :   * ANNOUNCES SIGNING OF A TERM SHEET  WITH JIANGSU RECBIO TECHNOLOGY CO. ON HPV VACCINES   * SPIMACO WILL RECEIVE AN EXCLUSIVE LICENSE TO IMPORT HPV IN FINISHED PRODUCT FORM,   * SPIMACO WILL RECEIVE AN EXCLUSIVE LICENSE TO  COMMERCIALIZE AND DISTRIBUTE RECBIO’S HPV VACCINE IN THE KINGDOM AND THE WIDER MENA REGION   * SPIMACO WILL RECEIVE AN EXCLUSIVE LICENSE TO LOCALIZE PRODUCTION OF HPV IN BULK FORMAT FOLLOWING CONCLUSION OF TECHNOLOGY TRANSFER   * MEMORANDUM DURATION 1 YEAR FROM DATE OF SIGNINGFurther company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02179":"瑞科生物-B","BK1161":"生物科技"},"translate_title":"Spimaco与江苏瑞科生物科技签署HPV疫苗条款清单","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02179":0.9},"content_text":"Jan 23 (Reuters) - SAUDI PHARMACEUTICAL INDUSTRIES AND MEDICAL APPLIANCES CORPORATION   :   * ANNOUNCES SIGNING OF A TERM SHEET (NON-BINDING) WITH JIANGSU RECBIO TECHNOLOGY CO. ON HPV VACCINES   * SPIMACO WILL RECEIVE AN EXCLUSIVE LICENSE TO IMPORT HPV IN FINISHED PRODUCT FORM,   * SPIMACO WILL RECEIVE AN EXCLUSIVE LICENSE TO  COMMERCIALIZE AND DISTRIBUTE RECBIO’S HPV VACCINE IN THE KINGDOM AND THE WIDER MENA REGION   * SPIMACO WILL RECEIVE AN EXCLUSIVE LICENSE TO LOCALIZE PRODUCTION OF HPV IN BULK FORMAT FOLLOWING CONCLUSION OF TECHNOLOGY TRANSFER   * MEMORANDUM DURATION 1 YEAR FROM DATE OF SIGNINGFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2405193039"}